Christoph M. Reuter

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer.

Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer.

Journal: Scientific reports

Published: June 12, 2024

Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.

Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 27, 2022

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?

Journal: World journal of urology

Published: March 23, 2022

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients.

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients.

Journal: Scientific reports

Published: April 26, 2021

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives.

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: March 02, 2021

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.

Journal: Oncology letters

Published: April 18, 2016

Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.

Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.

Journal: Annals of hematology

Published: March 10, 2014

A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.

A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.

Journal: European urology

Published: August 29, 2013

Outcome of surgical decompression of spinal mass lesions in non-Hodgkin's lymphoma and plasmacytoma.

Outcome of surgical decompression of spinal mass lesions in non-Hodgkin's lymphoma and plasmacytoma.

Journal: Clinical neurology and neurosurgery

Published: April 24, 2013

NADH dehydrogenase subunit 4 variant sequences in childhood acute myeloid leukaemia.

NADH dehydrogenase subunit 4 variant sequences in childhood acute myeloid leukaemia.

Journal: British journal of haematology

Published: March 26, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026